HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2022

Dimple Sethi Chopra

Speaker at Infectious Diseases Conference - Dimple Sethi Chopra
Punjabi University Patiala, India
Title : Multidrug Resistance in Burn Patients


Staphylococcus and Pseudomonas spp. are the most common cause of infection in patients suffering burn injuries. As burn patients have lost their primary protective barrier ie skin, they are susceptible to colonization by both endogenous and exogenous micro-organisms. The thermal injury itself decreases host resistance and increases the body’s natural inflammatory response. The burn eschar provides an environment conducive to bacterial growth because of its protein richness, release of toxic substances, and avascularity, which impedes the delivery of antimicrobial drugs. In the first five days, post-burn the most common pathogens are gram-positive, whereas gram negative bacteria increase in prevalence after five days. The most common pathogens in the early phase are Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, and Klebsiella. The most common late-phase pathogens include S. aureus and Pseudomonas aeruginosa. Yeast and fungal infections typically occur, around 7–14 days, post-burn, followed by multi-drug–resistant (MDR) infections. The crucial risk factors for Multidrug bacteria, include length of stay in hospital, previous antimicrobial therapy, inadequate burn excision, and use of invasive medical devices. Although, intravenous (IV) and intra-arterial catheters are used in burn patients to provide access for fluid resuscitation, parenteral nutrition, and administration of medications. But, they increase the risk of central line-associated blood stream infection (CLABSI). Diagnosis of MDR is difficult, as colonization usually precedes infection. Because of empiric treatment with broad-spectrum antibiotics during the initial burn treatment, resistance patterns and sensitivities vary. Pathogens of utmost concern are MDR strains of P. aeruginosa, Stenotrophomonas maltophilia, Acinetobacter, and methicillin-resistant S. aureus (MRSA). There also have been reports of outbreaks of carbapenem resistant Enterobacteriaceae in burn unit.


DR. DIMPLE SETHI CHOPRA  is presently working as  Associate  Professor (Pharmaceutics) in  Department   of  Pharmaceutical Sciences and Drug Research (DPDSR), Punjabi University, Patiala. She did her graduation and post-graduation from UIPS, Panjab University, Chandigarh. She joined DPDSR in 1998. She did her Ph.D under guidance of Professor Manjeet Singh. She has published several research papers in national and international journals of repute. She has been  granted two Indian patents on brain permeable nanoparticles. She is a member of American Nano Society.  She recently Edited a book published by IGI Global “ Strategies to Overcome Superbug Invasion”